Elevar Therapeutics Names Paul Friel Chief Commercial Officer, Michael Palucki VP of Manufacturing
May 23, 2022 10:15 ET | Elevar Therapeutics
SALT LAKE CITY, May 23, 2022 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who...
Madrigal logo.jpg
Madrigal Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences
May 17, 2022 08:00 ET | Madrigal Pharmaceuticals, Inc.
CONSHOHOCKEN, Pa., May 17, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic...
Stacked logo.png
Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR Targets for Drug Discovery
May 17, 2022 02:30 ET | Sosei Group Corporation
Collaboration is part of Sosei Heptares’ Target Identification and Validation (TIV) strategy to leverage multiple sophisticated technologies that drive creation of new drug discovery programs in key...
FTI_Logo_440x386.JPG
FTI Consulting Strengthens Health Solutions Practice with Addition of Anne Winter
May 16, 2022 07:30 ET | FTI Consulting, Inc.
WASHINGTON, May 16, 2022 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Anne Winter as a Senior Managing Director within the Company’s Health Solutions...
Stacked logo.png
Sosei Heptares Operational Highlights and Consolidated Results for the First Quarter 2022
May 13, 2022 02:30 ET | Sosei Group Corporation
TOKYO, Japan and CAMBRIDGE, United Kingdom, May 13, 2022 (GLOBE NEWSWIRE) -- Sosei Group Corporation (“the Company”; TSE: 4565) provides an update on operational activities and reports its...
Ki Young Sohn, CEO of Enzychem Lifesciences Honored by World Biz Magazine Leadership Awards With 'Top 100 Innovation CEO' Award
May 11, 2022 04:00 ET | World Biz Magazine
LONDON, May 11, 2022 (GLOBE NEWSWIRE) -- Ki Young Sohn is Chairman and CEO of Enzychem Lifesciences, a late-stage biotechnology company. With more than 30 years of experience in the life sciences...
researchdrivelogo.jpg
Global Health and Wellness Market Estimated to Surpass $6,543.4 Million by 2026, and Grow at a CAGR of 4.8% during the Forecast Period Exclusively Available [110-Pages] by Research Dive
May 10, 2022 09:10 ET | Research Dive
New York, USA, May 10, 2022 (GLOBE NEWSWIRE) -- Research Dive states that the global health and wellness market is estimated to garner a revenue of $6,543.4 million by 2026, and rise at a CAGR of...
Madrigal logo.jpg
Madrigal Pharmaceuticals Provides Clinical and Business Updates and Reports 2022 First Quarter Financial Results
May 09, 2022 06:30 ET | Madrigal Pharmaceuticals, Inc.
MAESTRO-NAFLD-1 late-breaker and three other Madrigal abstracts accepted for oral presentation at the EASL International Liver Congress™Data from the Phase 3 MAESTRO-NAFLD-1 study continue to...
MicrosoftTeams-image (5).png
Enteric Disease Testing Market to Expand with Rise in Demand for Early Disease Diagnosis, States TMR Study
May 06, 2022 11:30 ET | Transparency Market Research
Albany NY, United States, May 06, 2022 (GLOBE NEWSWIRE) -- The global enteric disease testing market is prognosticated to expand at a CAGR of 3.3% during the forecast period of 2019 to 2027, states...
Cellectis Logo.png
Calyxt, Inc., Cellectis’ Majority-Owned Subsidiary, Reports Its First Quarter 2022 Financial Results
May 05, 2022 16:14 ET | Cellectis Inc.
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- Cellectis S.A. (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop...